1. Home
  2. ICCC vs RECT Comparison

ICCC vs RECT Comparison

Compare ICCC & RECT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICCC
  • RECT
  • Stock Information
  • Founded
  • ICCC 1982
  • RECT 1997
  • Country
  • ICCC United States
  • RECT Singapore
  • Employees
  • ICCC N/A
  • RECT N/A
  • Industry
  • ICCC Biotechnology: Pharmaceutical Preparations
  • RECT
  • Sector
  • ICCC Health Care
  • RECT
  • Exchange
  • ICCC Nasdaq
  • RECT Nasdaq
  • Market Cap
  • ICCC 55.5M
  • RECT 53.6M
  • IPO Year
  • ICCC 1987
  • RECT 2024
  • Fundamental
  • Price
  • ICCC $6.19
  • RECT $2.12
  • Analyst Decision
  • ICCC
  • RECT
  • Analyst Count
  • ICCC 0
  • RECT 0
  • Target Price
  • ICCC N/A
  • RECT N/A
  • AVG Volume (30 Days)
  • ICCC 18.9K
  • RECT 1.0M
  • Earning Date
  • ICCC 11-13-2025
  • RECT 07-31-2025
  • Dividend Yield
  • ICCC N/A
  • RECT N/A
  • EPS Growth
  • ICCC N/A
  • RECT N/A
  • EPS
  • ICCC 0.20
  • RECT 0.12
  • Revenue
  • ICCC $28,274,756.00
  • RECT $32,594,177.00
  • Revenue This Year
  • ICCC N/A
  • RECT N/A
  • Revenue Next Year
  • ICCC N/A
  • RECT N/A
  • P/E Ratio
  • ICCC $31.45
  • RECT $18.65
  • Revenue Growth
  • ICCC 21.75
  • RECT 5.91
  • 52 Week Low
  • ICCC $3.38
  • RECT $2.00
  • 52 Week High
  • ICCC $7.60
  • RECT $7.68
  • Technical
  • Relative Strength Index (RSI)
  • ICCC 50.47
  • RECT 28.96
  • Support Level
  • ICCC $6.07
  • RECT $2.00
  • Resistance Level
  • ICCC $6.31
  • RECT $2.44
  • Average True Range (ATR)
  • ICCC 0.28
  • RECT 0.38
  • MACD
  • ICCC 0.01
  • RECT -0.07
  • Stochastic Oscillator
  • ICCC 44.19
  • RECT 5.71

About ICCC ImmuCell Corporation

ImmuCell Corp is engaged in the healthcare sector. The company operates in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. The company operates in two business segment. The Scours segment is dedicated to manufacturing and selling First Defense, a product used to prevent scours in newborn calves, which is regulated by the United States Department of Agriculture (USDA). The Mastitis segment is focused on developing and commercializing Re-Tain, a product to treat subclinical mastitis in lactating dairy cows, which is regulated by the United States Food and Drug Administration (FDA). The company generates the majority of its revenue from the Scours segment.

About RECT Rectitude Holdings Ltd

Rectitude Holdings Ltd is principally involved in the provision of safety equipment, encompassing essential items such as personal protective clothing, hand gloves, safety footwear, and personal fall arrest systems (a system used to arrest an employee in a fall from a walking-working surface, usually consisting of a body harness, anchorage, and connector), portable fire extinguishers and traffic products such as rubber speed humps, wheel stops and wheel chocks. Additionally the company has added auxiliary products such as industrial hardware tools and electrical hardware required for construction sites.

Share on Social Networks: